Clearly, more investigations are needed to confirm the participation of this adhesion molecule as well as other adhesion pathways (e.g., CD103 (αEβ7)) during the initial CAR T cell-tumor cell interaction. The gene discussed is ITGAE; the disease is neoplasm.